LAMPRENE Side Effects

6451602-2 | Diarrhoea, Eosinophil Count Increased, Granulomatous Liver Disease, Haemolytic Anaemia, Liver Function Test Abnormal
on Nov 12, 2009 Male patient from SOUTH AFRICA , 48 years of age, was diagnosed with leprosy and was treated with Lamprene (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, eosinophil count increased, granulomatous liver disease, haemolytic anaemia, liver function test abnormal. Lamprene dosage: . During the same period patient was treated with RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), DAPSONE (View Dapsone Review and Dapsone Label ).

5925545-4 | Abdominal Pain, Acute Respiratory Distress Syndrome, Gastrectomy, Gastric Perforation, Hiatus Hernia, Laparoscopic Surgery, Pathology Test, Post Procedural Complication, Soft Tissue Necrosis
Patient was taking Lamprene (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), acute respiratory distress syndrome, gastrectomy, gastric perforation, hiatus hernia, laparoscopic surgery, pathology test, post procedural complication, soft tissue necrosis on Oct 17, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 119.0 lb, was diagnosed with mycobacterium avium complex infection and. Lamprene dosage: 100 Mg, Qd. During the same period patient was treated with AZITHROMYCIN (500 Mg, Tid) (View Azithromycin Review and Azithromycin Label ), ETHAMBUTOL HYDROCHLORIDE (1000 Mg, Qd) (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), ATIVAN (View Ativan Review and Ativan Label ), CELEBREX (View Celebrex Review and Celebrex Label ), COLAZAL (View Colazal Review and Colazal Label ), LEVOTHROID (View Levothroid Review and Levothroid Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), ZOLOFT (View Zoloft Review and Zoloft Label ). Patient was hospitalized.

5092563-0 | Abdominal Pain, Accidental Exposure, Anaemia, Aspartate Aminotransferase Increased, Asthenia, Blood Alkaline Phosphatase Increased, Haematuria
Adverse event was reported on Aug 28, 2006 by a Female patient taking Lamprene (View Usage) (Dosage: 1 To 3 Tablets Once) . Location: FRANCE , child 2 years of age, After Lamprene was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), accidental exposure, anaemia, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, haematuria.

5059367-6 | Dermatitis Exfoliative
on Jul 03, 2006 Female patient from BRAZIL , 69 years of age, was treated with Lamprene (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis exfoliative. Lamprene dosage: 100 Mg. During the same period patient was treated with RIFAMPICIN (300 Mg) (View Rifampicin Review and Rifampicin Label ), DAPSONE (100 Mg) (View Dapsone Review and Dapsone Label ), THALIDOMIDE (View Thalidomide Review and Thalidomide Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.


4567769-7 | Anorexia, Skin Discolouration, Skin Nodule, Syncope
on Jan 12, 2005 Male patient from , 64 years of age, was treated with Lamprene (View Usage). Patient had the following side effects: anorexia, skin discolouration, skin nodule, syncope. Lamprene dosage: 5 Capsules/day, Oral. During the same period patient was treated with RIMACTANE (Unk) (View Rimactane Review and Rimactane Label ), DAPSONE (Unk) (View Dapsone Review and Dapsone Label ).

4563024-X | Anorexia, Chemical Poisoning, Skin Discolouration, Skin Nodule, Syncope
Patient was taking Lamprene (View Usage). After Lamprene was administered, patient had the following side effects: anorexia, chemical poisoning, skin discolouration, skin nodule, syncope on Jan 12, 2005 from Additional patient health information: Male patient , 64 years of age, . Lamprene dosage: 5 Capsules/day, Oral. During the same period patient was treated with RIMACTANE (View Rimactane Review and Rimactane Label ), DAPSONE (View Dapsone Review and Dapsone Label ).

4555896-X | Platelet Count Decreased
Adverse event was reported on Jan 07, 2005 by a Female patient taking Lamprene (View Usage) (Dosage: ) was diagnosed with myelodysplastic syndrome and. Location: , 70 years of age, Patient experienced the following unwanted or unexpected effects: platelet count decreased. During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ).